Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Clavubactin batches recalled over reduced efficacy
'This recall is because the efficacy of the product cannot be guaranteed after 12 months' - VMD.

Vets and wholesalers urged to examine their inventory immediately

The Veterinary Medicines Directorate (VMD) has issued a product defect recall alert for batches of the antibiotic Clavubactin, manufactured by Le Vet Pharma.

In a news release, the VMD writes: ‘We wish to make wholesalers and veterinary surgeons aware that Le Vet Pharma has issued a recall for batches of Clavubactin 50/12.5mg (Vm 19994/4028), Clavubactin 250/62.5mg (Vm 19994/4026), Clavubactin 500/125mg (Vm 19994/4027), all distributed by Animalcare and Dechra.

‘During routine stability testing the above-mentioned products do not fulfil the mandatory testing requirements at 24 months. This recall is because the efficacy of the product cannot be guaranteed after 12 months.’

The recall affects the following batches:

Product names Batch numbers Expiry
Clavubactin 50/12.5 mg 19D82 04-2021
  18D11 04-2020
  18G32 07-2020
Clavubactin 250/62.5 mg 19D83 04-2022
  17F46 06-2020
  17H35 08-2020
  18D13 04-2021
Clavubactin 500/125 mg 19D88 04-2022
  17C80 03-2020
  17F47 06-2020
  17H38 08-2020
  18D17 04-2021
  18D18 04-2021
  18G34 04-2022


Veterinary surgeons and wholesalers are urged to examine their inventory without delay and quarantine products subject to this recall.

For more information, please contact the relevant distributor:

Animalcare: Sameer Hashmi: shashmi@animalcare.co.uk
Dechra: Tracey Smith: tracey.smith@dechra.com

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.